Study Title | MyeChild-01: International Randomised Phase III Clinical Trial in Children with Acute Myeloid Leukaemia – Incorporating an Embedded Dose Finding Study for Gemtuzumab Ozogamicin in Combination with Induction Chemotherapy |
---|---|
Protocol ID | RG_14-088 (MyeChild-01) |
Disease (Sub Disease) | Acute Myeloid Leukaemia (AML) |
Diagnosis Stage | New diagnosis |
Sponsor | Australian and New Zealand Children's Haematology Oncology Group/ University of Birmingham |
Collaborators | Assistance Publique - Hôpitaux de Paris/ Cancer Research UK/ National Cancer Institute, France/ Pfizer |
Links | https://clinicaltrials.gov/ct2/show/NCT02724163 |
Trial Status | Closed to Recruitment |
Trial Open Date | 04/07/2018 |
Study Type | Treatment |
Phase | Phase 3 |
Age Eligibility | up to 18 years |
International registry ID's | NCT02724163 |